IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Kitov Pharmaceutical Holdings Ltd. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES--()--Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Kitov Pharmaceutical Holdings Ltd. (“Kitov” or the “Company”) (Nasdaq: KTOV) concerning possible violations of federal securities laws.

To get more information about this investigation, please click here, or contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via email at

On February 6, 2017, the Israeli publication Calcalist revealed that Kitov’s Chief Executive Officer, Isaac Israel, had been held by the Israeli Securities Authority regarding allegations of publishing misleading information about a recent clinical trial of one of Kitov’s products. When this information was disclosed to the investing public, the value of Kitov stock fell, causing investors harm.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125

Recent Stories

RSS feed for Lundin Law PC

Lundin Law PC